http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101132149-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-32 |
| filingDate | 2004-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101132149-B1 |
| titleOfInvention | Drug formulation and preparation method thereof |
| abstract | The present invention relates to a method for preparing a coated drug formulation or drug formulation in the form of a matrix containing the active substance. The drug formulation may be prepared by melting, injection molding, extruding, wet granulating, casting, dipping, applying, spraying a copolymer containing a pharmaceutically active substance, any core and / or conventional pharmaceutical excipients in a manner known per se. Or by compression to form a coated drug formulation and / or a drug formulation in the form of a matrix containing the active ingredient. The process comprises 20 to 33% by weight methacrylic acid, 5 to 30% by weight methyl acrylate, 20 to 40% by weight ethyl acrylate and 10% to 30% by weight butyl methacrylate and optionally, further vinyl copolymerization. A copolymer comprising 0 to 10% by weight of possible monomers and having a glass temperature of 55 to 70 ° C. according to ISO 11357-2, section 3.3.3 is used. The invention also relates to drug formulations, copolymers and uses thereof prepared according to the invention.n n n Coating drug formulations, copolymers, methacrylic acid, glass transition temperature, active ingredient matrix |
| priorityDate | 2003-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 455.